Opioid Dependence
📧 Sign up to get email alerts when something new happens for Opioid Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2020-10-08Clinical Trial Update: An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects. [Phase 4]
An open-label Phase 4 trial evaluating exposure–response for QTc changes with once-daily CASSIPA in opioid-dependent subjects was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects [Phase 3]
A Phase 3 trial evaluating BEMA Buprenorphine NX for induction in opioid-dependent subjects has been withdrawn. The study did not proceed to…
-
CLINICAL_TRIALS withdrawal · 2013-07-04Clinical Trial Update: Naloxone Methadone Combination (NAMEKO) [NA]
A clinical trial evaluating a naloxone-methadone combination (NAMEKO) for opioid dependence has been withdrawn.